C. Peña
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
C. Peña has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
F. Gudiol
Hospital Universitari de Bellvitge
7 shared publicationsJ. Ariza
Hospital Universitari de Bellvitge
7 shared publications- Miquel Pujol
VINCat Programme Surveillance of Healthcare Related Infections in Catalonia, Departament de Salut. Barcelona, Spain; Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain; Department of Infectious Diseases, Hospital Universitari de Bellvitge - IDIBELL. L'Hospitalet de Llobregat, Spain
7 shared publications F. Tubau
Hospital Universitari de Bellvitge
4 shared publications- Maria Angeles Dominguez
Microbiology Department, Hospital Universitari de Bellvitge, IDIBELL-UB
4 shared publications C. Gudiol
2 shared publications
Latest Publications
- 24 October 2008
- Published by Springer Nature in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 28 (5) , 519-522
Carbapenem-resistant Pseudomonas aeruginosa: factors influencing multidrug-resistant acquisition in non-critically ill patients
A cohort study was carried out on hospitalized adult non-critically ill patients (January 2003–December 2004) to identify factors associated with the acquisition of multidrug-resistant Pseudomonas aeruginosa (MDR-PA). A total of 246 non-critically patients were included, 162 (66%) who revealed MDR-PA in the first isolate and 84 (34%) who had carbapenem-resistant P. aeruginosa (CR-PA) isolates. Multivariate analysis identified nosocomial acquisition (odds ratio [OR] 2.7, 95% confidence interval [CI] 1.1–6.3), urinary catheter (OR 2.1, 95%CI 1.1–4.3), and the prior use of fluoroquinolones (OR 2.6, 95%CI 1.0–6.7) as independent risk factors associated with MDR-PA acquisition. Our results show that antibiotics, most notably, fluoroquinolones, may play a major role in the emergence of MDR-PA.
- 24 October 2008
- Published by Springer Nature in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 28 (5) , 519-522
Carbapenem-resistant Pseudomonas aeruginosa: factors influencing multidrug-resistant acquisition in non-critically ill patients
A cohort study was carried out on hospitalized adult non-critically ill patients (January 2003–December 2004) to identify factors associated with the acquisition of multidrug-resistant Pseudomonas aeruginosa (MDR-PA). A total of 246 non-critically patients were included, 162 (66%) who revealed MDR-PA in the first isolate and 84 (34%) who had carbapenem-resistant P. aeruginosa (CR-PA) isolates. Multivariate analysis identified nosocomial acquisition (odds ratio [OR] 2.7, 95% confidence interval [CI] 1.1–6.3), urinary catheter (OR 2.1, 95%CI 1.1–4.3), and the prior use of fluoroquinolones (OR 2.6, 95%CI 1.0–6.7) as independent risk factors associated with MDR-PA acquisition. Our results show that antibiotics, most notably, fluoroquinolones, may play a major role in the emergence of MDR-PA.
- 1 February 2008
- Published by Elsevier in Journal of Hospital Infection
- Vol. 68 (2) , 116-122
Infections due to Escherichia coli producing extended-spectrum β-lactamase among hospitalised patients: factors influencing mortality
- 1 February 2008
- Published by Elsevier in Journal of Hospital Infection
- Vol. 68 (2) , 116-122
Infections due to Escherichia coli producing extended-spectrum β-lactamase among hospitalised patients: factors influencing mortality
- 1 October 2007
- Published by Elsevier in Clinical Microbiology and Infection
- Vol. 13 (10) , 1026-1029
Nosocomial spread of Pseudomonas aeruginosa producing the metallo-β-lactamase VIM-2 in a Spanish hospital: clinical and epidemiological implications
- 1 October 2007
- Published by Elsevier in Clinical Microbiology and Infection
- Vol. 13 (10) , 1026-1029
Nosocomial spread of Pseudomonas aeruginosa producing the metallo-β-lactamase VIM-2 in a Spanish hospital: clinical and epidemiological implications
- 1 March 2006
- Published by Elsevier in Clinical Microbiology and Infection
- Vol. 12 (3) , 279-284
Risk-factors for acquisition of extended-spectrum β-lactamase-producing Escherichia coli among hospitalised patients
- 1 March 2006
- Published by Elsevier in Clinical Microbiology and Infection
- Vol. 12 (3) , 279-284
Risk-factors for acquisition of extended-spectrum β-lactamase-producing Escherichia coli among hospitalised patients
- 1 September 2004
- Published by Elsevier in Journal of Hospital Infection
- Vol. 58 (1) , 20-27
Staphylococcus aureus nasal carriage in patients on haemodialysis: role of cutaneous colonization
- 1 September 2004
- Published by Elsevier in Journal of Hospital Infection
- Vol. 58 (1) , 20-27
Staphylococcus aureus nasal carriage in patients on haemodialysis: role of cutaneous colonization
- 1 September 2003
- Published by Elsevier in Clinical Microbiology and Infection
- Vol. 9 (9) , 938-943
An outbreak of carbapenem-resistant Pseudomonas aeruginosa in a urology ward
- 1 September 2003
- Published by Elsevier in Clinical Microbiology and Infection
- Vol. 9 (9) , 938-943
An outbreak of carbapenem-resistant Pseudomonas aeruginosa in a urology ward
- 1 January 2001
- Published by Elsevier in Journal of Hospital Infection
- Vol. 47 (1) , 53-59
An outbreak of hospital-acquired Klebsiella pneumoniae bacteraemia, including strains producing extended-spectrum β-lactamase
- 1 January 2001
- Published by Elsevier in Journal of Hospital Infection
- Vol. 47 (1) , 53-59
An outbreak of hospital-acquired Klebsiella pneumoniae bacteraemia, including strains producing extended-spectrum β-lactamase